Maini S, Raghava N, Youngs R, Evans K, Trivedi S, Foy C, Mackintosh G
Department of Otolaryngology, Gloucestershire Royal Hospital, Gloucester, UK.
J Laryngol Otol. 2007 Dec;121(12):1170-6. doi: 10.1017/S0022215107009024. Epub 2007 Jun 29.
Rhinostomy patency is a problem in all forms of dacryocystorhinostomy. Laser-assisted procedures are potentially fast and result in excellent haemostasis. However, they may induce more fibroblastic activity, resulting in excessive scarring and stenosis of the rhinostomy, compared with non-laser dissection.
The objective of this study was to compare subjective outcomes following dacryocystorhinostomy conducted with endoscopic endonasal laser and with endonasal surgical techniques.
Prospective, randomised, controlled trial comparing potassium titanyl phosphate endonasal laser dissection with endonasal surgical techniques, for dacryocystorhinostomy to treat epiphora due to primary, acquired nasolacrimal duct obstruction.
One hundred and twenty-six adult patients with chronic epiphora due to primary, acquired nasolacrimal sac or duct obstruction.
INTERVENTIONS comprised endonasal dacryocystorhinostomy, performed using potassium titanyl phosphate laser or surgical dissection, in order to open the lacrimal sac into the nasal cavity.
These were: symptom score and symptom relief of epiphora (at three and 12 months post-procedure); duration and ease of procedure; and duration of hospital stay.
Sixty patients underwent endonasal laser dacryocystorhinostomy and 66 underwent endonasal surgical dacryocystorhinostomy. Symptomatic success was 82 per cent at three months and 68 per cent at 12 months in the laser group, and 76 per cent at three months and 74 per cent at 12 months in the surgical group. A two-point reduction in the symptom score was associated with symptomatic success at three and 12 months. Eight patients randomised to the laser group required additional instrumentation in order to remove thick bone over the lacrimal sac.
At three months, endonasal laser dacryocystorhinostomy had better results than endonasal surgical dacryocystorhinostomy. However, at 12 months, the surgical procedure had better results than the laser procedure. There was no statistically significant difference between the two groups at three or 12 months with regard to symptomatic outcome. The ease of procedure (on a scale of zero to 10) was 4.5 for the laser procedure and 4.1 for the surgical procedure. The average times for the procedures were 25 minutes in the laser group and 20 minutes in the surgical group. No statistical difference was found when comparing: symptom score improvement for local anaesthetic vs general anaesthetic; ages over and under 70 years; laterality; or operating surgeon. Change in the symptom score was a useful indicator of symptomatic success.
在各种形式的泪囊鼻腔造口术中,鼻造口通畅都是一个问题。激光辅助手术可能速度快且止血效果极佳。然而,与非激光剥离相比,它们可能会引发更多的成纤维细胞活动,导致鼻造口处过度瘢痕形成和狭窄。
本研究的目的是比较采用鼻内镜下鼻腔激光和鼻内手术技术进行泪囊鼻腔造口术后的主观结果。
前瞻性、随机、对照试验,比较磷酸钛钾鼻内镜下激光剥离与鼻内手术技术用于泪囊鼻腔造口术治疗原发性、后天性鼻泪管阻塞所致溢泪的效果。
126例因原发性、后天性鼻泪囊或鼻泪管阻塞导致慢性溢泪的成年患者。
干预措施包括使用磷酸钛钾激光或手术剥离进行鼻内镜下泪囊鼻腔造口术,以将泪囊开口于鼻腔。
这些指标包括:溢泪的症状评分和症状缓解情况(术后3个月和12个月);手术持续时间和难易程度;以及住院时间。
60例患者接受了鼻内镜下激光泪囊鼻腔造口术,66例接受了鼻内镜下手术泪囊鼻腔造口术。激光组术后3个月症状改善成功率为82%,12个月为68%;手术组术后3个月为76%,12个月为74%。症状评分降低2分与术后3个月和12个月的症状改善成功相关。随机分配到激光组的8例患者需要额外的器械操作以去除泪囊上方的厚骨。
术后3个月时,鼻内镜下激光泪囊鼻腔造口术的效果优于鼻内镜下手术泪囊鼻腔造口术。然而,在12个月时,手术操作的效果优于激光手术。两组在术后3个月或12个月时的症状改善结果在统计学上无显著差异。手术难易程度(0至10分)方面,激光手术为4.5分,手术操作为4.1分。手术平均时间激光组为25分钟,手术组为20分钟。在比较以下方面时未发现统计学差异:局部麻醉与全身麻醉的症状评分改善情况;70岁及以上和70岁以下患者;左右侧别;或手术医生。症状评分的变化是症状改善成功的一个有用指标。